10.1002/anie.201710227
Angewandte Chemie International Edition
COMMUNICATION
reactive and was converted in up to 93% to 2-oxodecanoic acid
in a 0.01% peroxide solution (Table S8).
Biotechnol. 2016, 42, 206-215; c) U. Biermann, U. Bornscheuer, M. A.
R. Meier, J. O. Metzger, H. J. Schafer, Angew. Chem. Int. Ed. 2011, 50,
3854-3871; d) K. Hill, Pure Appl. Chem. 2000, 72, 1255-1264.
P. R. Ortiz de Montellano, Chem. Rev. 2010, 110, 932-948.
a) R. T. Okita, J. R. Okita, Curr. Drug Metab. 2001, 2, 265-281; b) I.
Matsunaga, M. Yamada, E. Kusunose, Y. Nishiuchi, I. Yano, K.
Ichihara, FEBS Lett. 1996, 386, 252-254.
The internal recycling of H2O2 could be successfully
implemented in a three- and two-enzyme one-pot cascade for
the conversion of saturated fatty acids to -ketoacids. The
system displays attractive features, notably the use of peroxide
as 'catalytic' reagent in sub-stoichiometric amounts, as well as
high-atom efficiency and sustainable character of the reaction,
producing water as sole by product and using air as major
oxidant. With this setup, the use of P450 monooxygenases in
the peroxygenase mode at low H2O2 concentration (≤0.01%)
appears attractive for synthetic applications, owing to improved
enzyme lifetime. Additionally, non-enzymatic oxidative
decarboxylation of 2-oxoacid products is completely avoided and
no reaction engineering technique (e.g. in situ product removal)
is required. Altogether, the biocatalytic oxidative cascade
combining P450s in the peroxygenase mode with -hydroxyacid
oxidase(s) is a promising tool for functionalization of bio-based
chemicals and contributes to more sustainable synthetic routes.
[2]
[3]
[4]
a) R. Bernhardt, J. Biotechnol. 2006, 124, 128-145; b) I. G. Denisov, S.
G. Sligar in Cytochrome P450 (Ed.: P. R. Ortiz de Montellano), Springer,
Heidelberg, 2015, pp. 69-109.
[5]
[6]
I. N. A. Van Bogaert, S. Groeneboer, K. Saerens, W. Soetaert, FEBS J.
2011, 278, 206-221.
a) I. G. Denisov, T. M. Makris, S. G. Sligar, I. Schlichting, Chem. Rev.
2005, 105, 2253-2277; b) O. Shoji, Y. Watanabe, J. Biol. Inorg. Chem.
2014, 19, 529-539; c) V. B. Urlacher, M. Girhard, Trends Biotechnol.
2012, 30, 26-36.
[7]
[8]
[9]
I. Matsunaga, A. Ueda, N. Fujiwara, T. Sumimoto, K. Ichihara, Lipids
1999, 34, 841-846.
M. Girhard, S. Schuster, M. Dietrich, P. Durre, V. B. Urlacher, Biochem.
Biophys. Res. Commun. 2007, 362, 114-119.
M. A. Rude, T. S. Baron, S. Brubaker, M. Alibhai, S. B. Del Cardayre,
A. Schirmer, Appl. Environ. Microbiol. 2011, 77, 1718-1727.
[10] a) A. W. Munro, H. M. Girvan, A. E. Mason, A. J. Dunford, K. J.
McLean, Trends Biochem. Sci 2013, 38, 140-150; b) R. Fasan, ACS
Catal. 2012, 2, 647-666; c) M. Girhard, E. Kunigk, S. Tihovsky, V. V.
Shumyantseva, V. B. Urlacher, Biotechnol. Appl. Biochem. 2013, 60,
111-118.
Experimental Section
Reactions were performed in duplicates in closed glass-vials in 1 mL
buffer (KPi, 100 mM, pH 7.4), as described in the text. Derivatization for
GC and GC-MS analysis was performed by silylation of the organic
phase (Figure S8-S12). Protocols for production of all biocatalysts,
reaction conditions and analytical methods can be found in the
supporting information. P450SPα was produced using pDB-HisGST vector
obtained from the DNASU plasmid repository (deposit from Berkeley
Structural Genomics Center).[20]
[11] S. Lütz, E. Steckhan, A. Liese, Electrochem. Commun. 2004, 6, 583-
587.
[12] Y. Ni, E. Fernandez-Fueyo, A. G. Baraibar, R. Ullrich, M. Hofrichter, H.
Yanase, M. Alcalde, W. J. H. van Berkel, F. Hollmann, Angew. Chem.
Int. Ed. 2016, 55, 798-801.
[13] a) C. E. Paul, E. Churakova, E. Maurits, M. Girhard, V. B. Urlacher, F.
Hollmann, Biorg. Med. Chem. 2014, 22, 5692-5696; b) D. I. Perez, M.
M. Grau, I. W. C. E. Arends, F. Hollmann, Chem. Commun. 2009,
6848-6850; c) E. Churakova, M. Kluge, R. Ullrich, I. Arends, M.
Hofrichter, F. Hollmann, Angew. Chem. Int. Ed. 2011, 50, 10716-10719;
d) D. S. Choi, Y. Ni, E. Fernandez-Fueyo, M. Lee, F. Hollmann, C. B.
Park, ACS Catal. 2017, 7, 1563-1567.
Acknowledgements
Prof. Xu and Dr. Gao (Shandong University, China) are thanked
for plasmid preparation of GO-LOX. Tamara Reiter is thanked
for her excellent assistance. Financial support by the Austrian
Science Fund (FWF) within the DK “Molecular Enzymology”
program (project no. W901) is gratefully acknowledged. Funding
by the Austrian BMWFW, BMVIT, SFG, Standortagentur Tirol,
Government of Lower Austria and ZIT through the Austrian
FFG-COMET-Funding Program is gratefully acknowledged.
[14] J. H. Schrittwieser, S. Velikogne, M. Hall, W. Kroutil, Chem Rev., DOI:
10.1021/acs.chemrev.7b00033.
[15] A. Dennig, M. Kuhn, S. Tassoti, A. Thiessenhusen, S. Gilch, T. Bülter,
T. Haas, M. Hall, K. Faber, Angew. Chem. Int. Ed. 2015, 54, 8819-
8822.
[16] E. Koubek, M. L. Haggett, C. J. Battaglia, K. M. Ibne-Rasa, H. V. Pyun,
J. O. Edwards, J. Am. Chem. Soc. 1963, 85, 2263-2268.
[17] K. Yorita, K. Aki, T. Ohkuma-Soyejima, T. Kokubo, H. Misaki, V.
Massey, J. Biol. Chem. 1996, 271, 28300-28305.
[18] B. B. Sheng, J. Xu, Y. S. Ge, S. Zhang, D. Q. Wang, C. Gao, C. Q. Ma,
P. Xu, ChemCatChem 2016, 8, 2630-2633.
Keywords: P450 • 2-hydroxyacid oxidase • H2O2 recycling •
biocatalysis • bio-based chemicals
[19] a) T. Fujishiro, O. Shoji, S. Nagano, H. Sugimoto, Y. Shiro, Y.
Watanabe, J. Biol. Chem. 2011, 286, 29941-29950; b) R. Ramanan, K.
D. Dubey, B. J. Wang, D. Mandal, S. Shaik, J. Am. Chem. Soc. 2016,
138, 6786-6797.
[20] C. Y. Seiler, J. G. Park, A. Sharma, P. Hunter, P. Surapaneni, C.
Sedillo, J. Field, R. Algar, A. Price, J. Steel, A. Throop, M. Fiacco, J.
LaBaer, Nucleic Acids Res. 2014, 42, D1253-D1260.
[1]
a) J. C. Philp, R. J. Ritchie, J. E. M. Allan, Trends Biotechnol. 2013, 31,
219-222; b) S. Kim, S. Cheong, A. Chou, R. Gonzalez, Curr. Opin.
This article is protected by copyright. All rights reserved.